Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Buy
51
COCSF Quote, Financials, Valuation and Earnings
Last price:
$9.3500
Seasonality move
:
1.16%
Day range:
$9.5250 - $9.5250
52-week range:
$7.0000 - $10.1400
Dividend yield:
0%
P/E ratio:
16.02x
P/S ratio:
1.34x
P/B ratio:
2.69x
Volume:
479
Avg. volume:
1K
1-year change:
9.11%
Market cap:
$20B
Revenue:
$15.4B
EPS (TTM):
$0.59
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Coca-Cola Femsa SAB de CV has -- downside to fair value with a price target of -- per share.
COCSF vs. S&P 500
-
Over the past 5 trading days, Coca-Cola Femsa SAB de CV has underperformed the S&P 500 by -1.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Coca-Cola Femsa SAB de CV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Coca-Cola Femsa SAB de CV revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Coca-Cola Femsa SAB de CV reported revenues of $3.4B.
Earnings Growth
-
Coca-Cola Femsa SAB de CV earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Coca-Cola Femsa SAB de CV reported earnings per share of $0.12.
Enterprise value:
22.6B
EV / Invested capital:
1.96x
Price / LTM sales:
1.34x
EV / EBIT:
10.38x
EV / Revenue:
1.51x
PEG ratio (5yr expected):
3.48x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
10.38x
Gross Profit (TTM):
$6.9B
Return On Assets:
7.97%
Net Income Margin (TTM):
8.37%
Return On Equity:
16.62%
Return On Invested Capital:
11.13%
Operating Margin:
13.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $11.8B | $14.5B | $14.9B | $3.8B | $3.4B | |
| Gross Profit | $5.2B | $6.6B | $6.9B | $1.7B | $1.6B | |
| Operating Income | $1.6B | $2B | $2B | $504.6M | $448.5M | |
| EBITDA | $1.6B | $2B | $2.2B | $547.6M | $491.6M | |
| Diluted EPS | $0.49 | $0.57 | $0.59 | $0.14 | $0.12 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.6B | $4.2B | -- | $4.2B | $3.6B | |
| Total Assets | $12.7B | $14.3B | -- | $16.7B | $15.3B | |
| Current Liabilities | $2.4B | $3.1B | -- | $4B | $3B | |
| Total Liabilities | $7.2B | $8.1B | -- | $9.2B | $7.5B | |
| Total Equity | $5.5B | $6.2B | -- | $7.6B | $7.8B | |
| Total Debt | $4.3B | $4.2B | -- | $3.9B | $3.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-25 | 2024-06-25 | 2024-06-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
COCSF
Sector
Market Cap
$20B
--
Price % of 52-Week High
93.94%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
9.11%
--
Beta (5-Year)
0.570
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$9.6250
200-day SMA
Buy
Level
$8.6819
Bollinger Bands (100)
Buy
Level
8.4629 - 9.7029
Chaikin Money Flow
Buy
Level
301.3K
20-day SMA
Buy
Level
$9.5123
Relative Strength Index (RSI14)
Buy
Level
50.2401
ADX Line
Buy
Level
6.1145
Williams %R
Neutral
Level
-55.8824
50-day SMA
Buy
Level
$9.4801
MACD (12, 26)
Buy
Level
0.0778
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Sell
Level
-193.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2916)
Buy
CA Score
(Annual)
Level (0.4133)
Buy
Beneish M-Score
(Annual)
Level (-2.9437)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.2519)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of wide-moat Coca-Cola in unit case volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through on-trade and off-trade channels, including retailers and food-service providers. Mexico and Brazil make up 80% of total sales for Coca-Cola Femsa, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Parent Femsa and Coca-Cola hold 47% and 28% of economic interests in Coca-Cola Femsa, through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the respective voting rights.
Stock Forecast FAQ
In the current month, COCSF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The COCSF average analyst price target in the past 3 months is --.
-
Where Will Coca-Cola Femsa SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Coca-Cola Femsa SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Coca-Cola Femsa SAB de CV?
Analysts are divided on their view about Coca-Cola Femsa SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Coca-Cola Femsa SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Coca-Cola Femsa SAB de CV's Price Target?
The price target for Coca-Cola Femsa SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is COCSF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Coca-Cola Femsa SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of COCSF?
You can purchase shares of Coca-Cola Femsa SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Coca-Cola Femsa SAB de CV shares.
-
What Is The Coca-Cola Femsa SAB de CV Share Price Today?
Coca-Cola Femsa SAB de CV was last trading at $9.3500 per share. This represents the most recent stock quote for Coca-Cola Femsa SAB de CV. Yesterday, Coca-Cola Femsa SAB de CV closed at $9.5250 per share.
-
How To Buy Coca-Cola Femsa SAB de CV Stock Online?
In order to purchase Coca-Cola Femsa SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
59
NKTR alert for Jun 25
Nektar Therapeutics [NKTR] is up 20.86% over the past day.
Buy
58
AMBA alert for Jun 25
Ambarella [AMBA] is up 3.65% over the past day.
Buy
65
EXOD alert for Jun 25
Exodus Movement [EXOD] is down 8.81% over the past day.
